Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs

Biocompatible materials that can control crystallization while carrying large amounts of active pharmaceutical ingredients (APIs) with diverse chemical properties are in demand in industrial practice. In this study, we investigate the utility of biocompatible alginate (ALG) hydrogels as a rational m...

Full description

Bibliographic Details
Main Authors: Eral, Huseyin Burak, Lopez-Mejias, Vilmali, O'Mahony, Marcus, Myerson, Allan S. Trout, Bernhard L., Myerson, Allan S., Doyle, Patrick S.
Other Authors: Novartis-MIT Center for Continuous Manufacturing
Format: Article
Language:en_US
Published: American Chemical Society (ACS) 2015
Online Access:http://hdl.handle.net/1721.1/96912
https://orcid.org/0000-0003-1417-9470
https://orcid.org/0000-0002-7352-5962
_version_ 1811068969927311360
author Eral, Huseyin Burak
Lopez-Mejias, Vilmali
O'Mahony, Marcus
Myerson, Allan S. Trout, Bernhard L.
Myerson, Allan S.
Doyle, Patrick S.
author2 Novartis-MIT Center for Continuous Manufacturing
author_facet Novartis-MIT Center for Continuous Manufacturing
Eral, Huseyin Burak
Lopez-Mejias, Vilmali
O'Mahony, Marcus
Myerson, Allan S. Trout, Bernhard L.
Myerson, Allan S.
Doyle, Patrick S.
author_sort Eral, Huseyin Burak
collection MIT
description Biocompatible materials that can control crystallization while carrying large amounts of active pharmaceutical ingredients (APIs) with diverse chemical properties are in demand in industrial practice. In this study, we investigate the utility of biocompatible alginate (ALG) hydrogels as a rational material for crystallizing and encapsulating model APIs that present drastically different solubilities in water. Acetaminophen (ACM) and fenofibrate (FEN) are utilized as the model hydrophilic and hydrophobic moieties, respectively. ALG hydrogels with different ALG concentrations (hence different mesh sizes) are utilized as heteronucleants to control the nucleation kinetics of ACM from solution. ALG hydrogels with smaller mesh sizes showed faster nucleation kinetics. We hypothesize that this behavior is due to the interplay between the polymer–solute interactions and the mesh-induced confinement effects. The loading of ACM into hydrogels by equilibrium partitioning is quantified and found to be inversely proportional to ALG concentration. For hydrophobic model APIs, loading via equilibrium partitioning is inefficient; hence, we suggest emulsion-laden hydrogels where emulsion droplets are encapsulated inside the hydrogel matrix. The incorporation of emulsion droplets inside hydrogels enables the high loading of the hydrophobic API leveraging the high solubility of the hydrophobic API in the dispersed emulsion droplets. By carefully choosing the emulsification method and the dispersed phase, we demonstrate significant loading (up to ∼80% w/w) and crystallization of the stable form of FEN. Our results provide new insights for designing biocompatible nucleation-active materials capable of carrying industrially significant amounts of water-soluble and insoluble APIs in the crystalline form.
first_indexed 2024-09-23T08:03:37Z
format Article
id mit-1721.1/96912
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T08:03:37Z
publishDate 2015
publisher American Chemical Society (ACS)
record_format dspace
spelling mit-1721.1/969122022-09-30T07:10:44Z Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs Eral, Huseyin Burak Lopez-Mejias, Vilmali O'Mahony, Marcus Myerson, Allan S. Trout, Bernhard L. Myerson, Allan S. Doyle, Patrick S. Novartis-MIT Center for Continuous Manufacturing Massachusetts Institute of Technology. Department of Chemical Engineering Eral, Huseyin Burak Eral, Huseyin Burak Lopez-Mejias, Vilmali O'Mahony, Marcus Trout, Bernhardt L. Myerson, Allan S. Doyle, Patrick S. Biocompatible materials that can control crystallization while carrying large amounts of active pharmaceutical ingredients (APIs) with diverse chemical properties are in demand in industrial practice. In this study, we investigate the utility of biocompatible alginate (ALG) hydrogels as a rational material for crystallizing and encapsulating model APIs that present drastically different solubilities in water. Acetaminophen (ACM) and fenofibrate (FEN) are utilized as the model hydrophilic and hydrophobic moieties, respectively. ALG hydrogels with different ALG concentrations (hence different mesh sizes) are utilized as heteronucleants to control the nucleation kinetics of ACM from solution. ALG hydrogels with smaller mesh sizes showed faster nucleation kinetics. We hypothesize that this behavior is due to the interplay between the polymer–solute interactions and the mesh-induced confinement effects. The loading of ACM into hydrogels by equilibrium partitioning is quantified and found to be inversely proportional to ALG concentration. For hydrophobic model APIs, loading via equilibrium partitioning is inefficient; hence, we suggest emulsion-laden hydrogels where emulsion droplets are encapsulated inside the hydrogel matrix. The incorporation of emulsion droplets inside hydrogels enables the high loading of the hydrophobic API leveraging the high solubility of the hydrophobic API in the dispersed emulsion droplets. By carefully choosing the emulsification method and the dispersed phase, we demonstrate significant loading (up to ∼80% w/w) and crystallization of the stable form of FEN. Our results provide new insights for designing biocompatible nucleation-active materials capable of carrying industrially significant amounts of water-soluble and insoluble APIs in the crystalline form. Novartis-MIT Center for Continuous Manufacturing 2015-05-05T16:35:50Z 2015-05-05T16:35:50Z 2014-02 2014-02 Article http://purl.org/eprint/type/JournalArticle 1528-7483 1528-7505 http://hdl.handle.net/1721.1/96912 Eral, Huseyin Burak, Vilmali Lopez-Mejias, Marcus O’Mahony, Bernhard L. Trout, Allan S. Myerson, and Patrick S. Doyle. “Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs.” Crystal Growth & Design 14, no. 4 (April 2, 2014): 2073–2082. https://orcid.org/0000-0003-1417-9470 https://orcid.org/0000-0002-7352-5962 en_US http://dx.doi.org/10.1021/cg500250e Crystal Growth & Design Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf American Chemical Society (ACS) Eral
spellingShingle Eral, Huseyin Burak
Lopez-Mejias, Vilmali
O'Mahony, Marcus
Myerson, Allan S. Trout, Bernhard L.
Myerson, Allan S.
Doyle, Patrick S.
Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs
title Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs
title_full Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs
title_fullStr Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs
title_full_unstemmed Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs
title_short Biocompatible Alginate Microgel Particles as Heteronucleants and Encapsulating Vehicles for Hydrophilic and Hydrophobic Drugs
title_sort biocompatible alginate microgel particles as heteronucleants and encapsulating vehicles for hydrophilic and hydrophobic drugs
url http://hdl.handle.net/1721.1/96912
https://orcid.org/0000-0003-1417-9470
https://orcid.org/0000-0002-7352-5962
work_keys_str_mv AT eralhuseyinburak biocompatiblealginatemicrogelparticlesasheteronucleantsandencapsulatingvehiclesforhydrophilicandhydrophobicdrugs
AT lopezmejiasvilmali biocompatiblealginatemicrogelparticlesasheteronucleantsandencapsulatingvehiclesforhydrophilicandhydrophobicdrugs
AT omahonymarcus biocompatiblealginatemicrogelparticlesasheteronucleantsandencapsulatingvehiclesforhydrophilicandhydrophobicdrugs
AT myersonallanstroutbernhardl biocompatiblealginatemicrogelparticlesasheteronucleantsandencapsulatingvehiclesforhydrophilicandhydrophobicdrugs
AT myersonallans biocompatiblealginatemicrogelparticlesasheteronucleantsandencapsulatingvehiclesforhydrophilicandhydrophobicdrugs
AT doylepatricks biocompatiblealginatemicrogelparticlesasheteronucleantsandencapsulatingvehiclesforhydrophilicandhydrophobicdrugs